Rainbow Childrens MED Ltd

NSE: RAINBOW · Hospital · sector

₹1,162.00NSE close 2026-10-26

Key numbers

Market cap₹11,802 cr

Price₹1,162.00

52w high / low₹1,610 / ₹1,084

P/E41.3xSector median 42.5x

P/B7.2xSector median 4.9x

Book value₹162.3

Dividend yield0.26%Sector median 0.17%

ROE18.3%Sector median 12.1%

ROCE27.4%Sector median 13.8%

OPM31.5%Sector median 20.3%

Debt / equity0.00xSector median 0.24x

EV/EBITDA19.8xSector median 23.6x

Interest cover5.6x

Current ratio3.59x

Sales growth 3y+13.2%Sector median +14.1%

Profit growth 3y+9.7%Sector median +14.7%

PEG4.36x

Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 32 companies in Hospital (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Cash ₹438 cr vs borrowings ₹0 cr (FY26): cash is higher (net cash).
Operating profit covered interest 5.6x in the last 12 months.
Operating cash flow was below net profit in 0 of the last 5 years.
Revenue was higher than a year earlier in 4 of the last 4 quarters.
Other income was 13% of net profit in the last 12 months.
Dividend paid in 4 of the last 5 financial years.
Price ₹1,162.00 on 2026-10-26: -27.8% from the 52-week high, +7.2% from the 52-week low.

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹1,645.75 · low ₹1,106.00

Quarterly results

₹ cr	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	417	398	370	353	445	445	460	470
EBITDA	147	134	115	104	149	147	143	135
OPM %	35.2%	33.8%	31.0%	29.4%	33.5%	33.0%	31.1%	28.6%
Other income	11	13	15	20	8	11	5	13
Net profit	79	69	56	54	75	73	77	61
EPS (₹)	7.77	6.76	5.55	5.27	7.41	7.14	7.59	5.97
Revenue YoY					+6.5%	+11.9%	+24.3%	+33.2%
Profit YoY					-4.6%	+5.6%	+36.7%	+13.2%

Consolidated figures where filed. Latest quarter Jun 2026.

Profit & loss (yearly)

₹ cr	FY22	FY23	FY24	FY25	FY26	TTM
Revenue	974	1,174	1,297	1,516	1,703	1,820
EBITDA	305	396	429	490	543	574
Net profit	138	211	217	243	278	285
EPS (₹)	14.75	20.89	21.38	23.97	27.41	28.11
Revenue growth		+20.5%	+10.5%	+16.9%	+12.4%	+18.3%
Profit growth		+52.5%	+2.9%	+12.2%	+14.3%	+10.9%
Dividend / share (₹)	–	2.00	3.00	3.00	3.00

Compounded growth	3 years	5 years	Last 12 months
Sales	+13.2%	–	+18.3%
Net profit	+9.7%	–	+10.9%
EPS	+9.5%	–	–
Share price	–	-6.9% (2y)	-11.1%

Balance sheet

₹ cr	FY22	FY23	FY24	FY25	FY26
Shareholders' equity	–	1,060	1,259	1,468	1,648
Borrowings	–	0	0	0	0
Cash & equivalents	–	104	318	591	438
Total assets	–	1,776	2,170	2,377	2,775
Fixed assets	–	928	1,249	1,388	1,562
Capital work in progress	–	21	14	28	76
Investments	–	0	0	0	0
Receivables	–	58	70	77	103
Inventory	–	19	24	28	42
Payables	–	84	82	91	101

Year-end figures from the March annual filing.

Cash flow

₹ cr	FY22	FY23	FY24	FY25	FY26
Cash from operations	224	327	321	396	420
Cash from investing	-175	-465	-226	-268	-259
Cash from financing	-44	143	-102	-118	-147
Capex	62	141	354	146	216
Free cash flow	162	186	-32	250	203

Free cash flow = cash from operations − capex.

Ratios by year

₹ cr	FY22	FY23	FY24	FY25	FY26
ROE %	–	19.9%	17.2%	16.6%	16.9%
ROCE %	–	31.8%	28.1%	27.4%	26.4%
Debtor days	–	18	20	19	22
Inventory days	–	43	53	52	67
Payable days	–	195	180	170	162
Cash conversion cycle (days)	–	-134	-107	-99	-73
Working capital days	–	105	133	164	103

Shareholding

Holder	% (2026-09-30)
Promoters	49.83%
FIIs	14.66%
DIIs	23.28%
of which Mutual funds	18.84%
of which Insurance	2.76%
Public (non-institutions)	11.83%

Quarter	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters %	49.85%	49.85%	49.85%	49.85%	49.84%	49.84%	49.84%	49.83%

Promoter group	%
Ramesh Kancharla	31.03%
Chirla Dinesh Kumar Padmarao	6.53%
Adarsh Kancharla	6.02%
Ramesh Kancharla	5.13%
Chirla Dineshkumar Padma RAO	1.02%
Srinivas Talasila	0.06%
Ramadhara Naidu K	0.05%

Public holders above 1%	%
ICICI Prudential Healthcare Fund	5.50%
DSP Flexi CAP Fund	3.42%
Franklin Templeton Investment Funds - Franklin IND	2.20%
HDFC Life Insurance Company Limited	2.10%
ABU Dhabi Investment Authority - Monsoon	2.06%
Titanium Equity Long-short Fund	1.88%
Nippon Life India Trustee Ltd- A/C Nippon India VI	1.63%
Axis Mutual Fund Trustee Limited A/C Axis Mutual F	1.57%
Motilal Oswal Nifty Smallcap 250 Index Fund	1.51%
Nagalakshmi Devineni	1.18%
Poddutoor Preetham Kumar	1.07%

92,814 shareholders. Pledged: – of promoter shares.

Peers in Hospital

Company	Market cap	P/E	P/B	ROE	ROCE	OPM	Sales 3y	Div yield
APOLLOHOSP	₹1,12,797 cr	54.0x	11.9x	23.6%	21.8%	15.1%	+14.9%	0.26%
MAXHEALTH	₹81,266 cr	55.7x	7.6x	14.5%	13.8%	26.1%	+22.4%	0.18%
MANIPALHOS	₹73,581 cr	–	–	–	–	–	–	–
FORTIS	₹55,467 cr	52.9x	5.6x	11.1%	13.2%	22.2%	+13.2%	0.14%
NH	₹33,971 cr	41.4x	7.5x	20.0%	13.7%	18.7%	+20.4%	0.26%
ASTERDM	₹33,523 cr	104.7x	7.3x	8.0%	12.8%	16.7%	-27.0%	0.16%
MEDANTA	₹32,575 cr	58.5x	8.2x	15.1%	15.8%	20.5%	+17.9%	0.04%
KIMS	₹28,123 cr	131.3x	12.5x	9.3%	9.6%	19.5%	+21.1%	0.74%
AGARWALEYE	₹15,065 cr	101.3x	7.4x	7.6%	16.5%	27.8%	–	0.01%
RAINBOW	₹11,802 cr	41.3x	7.2x	18.3%	27.4%	31.5%	+13.2%	0.26%

All 32 companies in Hospital →

Dividends & corporate actions

Ex-date	Action	Detail
2026-07-21	Dividend	Dividend - Rs 3.50 Per Share
2025-06-27	Dividend	Dividend - Rs 3 Per Share
2024-07-23	Dividend	Annual General Meeting/Dividend - Rs 3 Per Share
2023-06-22	Dividend	Annual General Meeting/Dividend - Rs 3 Per Share
2022-09-07	Dividend	Annual General Meeting/Dividend - Rs 2 Per Share

Documents

Links go to the original files on the exchange website.

About the company

Human Health Activities: Medical services


Sector	Healthcare
Industry	Hospital
Sub-industry	Hospital
Symbol	RAINBOW
BSE code	543524
ISIN	INE961O01016
Face value	₹10.0
Incorporated	1998-08-07
Website	www.rainbowhospitals.in
Plants (India / abroad)	28 / 0

From the company's filings (BRSR FY26).

Data built 2026-10-22 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.